key: cord-1002100-q8jpyew7 authors: Marcinkowska, Ewa; Brown, Geoffrey title: Editorial: Vitamin D and COVID-19: New Mechanistic and Therapeutic Insights date: 2022-03-15 journal: Front Pharmacol DOI: 10.3389/fphar.2022.882046 sha: dd86d442de5b32258a0722e78fac52d63602954b doc_id: 1002100 cord_uid: q8jpyew7 nan maintaining calcium-phosphate homeostasis (Holick, 1996) . However, it is also well known that 1,25D regulates genes involved in the function of immune cells, for example, CD14, which is the macrophage co-receptor for bacterial lipopolysaccharide (LPS) (Carlberg et al., 2013) . Recent research has documented around 200 genes which are directly regulated by liganded VDR in human blood cells, and around 500 secondary targets (Hanel and Carlberg, 2022) . The cells that appear to be the key targets of 1,25D regulation in the immune system are macrophages and dendritic cells. They have a high VDR expression level (Carlberg et al., 2013) and can produce 1,25D from its precursor 25D (Dusso et al., 1991) . 1,25D directly regulates the expression of genes that are crucial to the functions of macrophages and dendritic cells, such as CD14 (Gombart et al., 2005; Carlberg, 2014b) , cathelicidin (Liu et al., 2007) , and TNFα (Cohen et al., 2001) . However, the influence of 1,25D on the human innate immune response is complex because it has been shown that pre-treatment of human monocytes with 1,25D reduced their production of TNF-α and interleukin-(IL-) 6 in response to bacterial LPS (Zhang et al., 2012) . Noteworthy, for around 700 genes regulated by VDR in human blood cells, the majority have been linked to downregulation of neutrophil degranulation, chemokine production, IFNγ-mediated signal transduction, and IL-6 production (Hanel and Carlberg, 2022) . When a virus infects the human body, the innate defenses are activated. Infected cells produce interferons α and β, which diffuse to neighboring cells to render them into an antiviral state. The virus-infected cells downregulate MHC class I molecules, whereby they are targets for killing by natural killer cells. Eventually, macrophages, using their toll-like receptors, may recognize the virus particles, phagocytose them, produce nitric oxide within phagolysosomes, and secrete defensins, cathelicidin, or TNFα into their environment. When innate responses are insufficient to eliminate the virus, adaptive immune mechanisms are activated. The most efficient process is the destruction of virus-infected cells by cytotoxic T lymphocytes, which recognize viral peptides that are presented at the cell surface of infected cells by MHC class I molecules. In addition, B lymphocytes may recognize certain patterns present in the viral envelope and then differentiate into plasma cells to produce a large number of antibodies. Both actions are under tight control by T helper cells (Delves et al., 2017) . However, viral infections may lead to excessive immune responses, such as a cytokine storm (CS). This is a dangerous immune condition characterized by a release of about 150 inflammatory cytokines and mediators of inflammation (Delves et al., 2017) . CS can lead to severe complications such as high fever, intravascular coagulation, tissue damage, multiple organ failure, and death (Wong et al., 2017) . Walsh et al. examined how some of these lifethreatening events may be attenuated by a sufficient level of 1,25D. There are no unwanted side effects for taking vitamin D to ensure a proper level of 25D. Accordingly, Walsh et al. published their recommendations of "a vitamin D intake of 800-1000 IU per day, with a higher and monitored dose, e.g., 1,500-2000 IU per day, for vulnerable groups who have a confirmed or a likely low vitamin D status". Whether vitamin D can provide an adjunct to therapy for patients who already have COVID-19 remains an open question. The data discussed by Tomaszewska et al. indicate that 25D (calcifediol), rather than vitamin D, should be used therapeutically. EM wrote the draft of the text, which was revised by GB. Nuclear Hormone Receptors and Gene Expression Primary Vitamin D Target Genes Allow a Categorization of Possible Benefits of Vitamin D₃ Supplementation The Physiology of Vitamin D-Far More Than Calcium and Bone Genome-wide (Over)view on the Actions of Vitamin D Accuracy of 25-hydroxyvitamin D Assays: Confronting the Issues Regulation of TNF-Alpha by 1alpha,25-Dihydroxyvitamin D3 in Human Macrophages from CAPD Patients Extrarenal Production of Calcitriol in normal and Uremic Humans Human Cathelicidin Antimicrobial Peptide (CAMP) Gene Is a Direct Target of the Vitamin D Receptor and Is Strongly Up-Regulated in Myeloid Cells by 1,25-dihydroxyvitamin D3 A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health Time-Resolved Gene Expression Analysis Monitors the Regulation of Inflammatory Mediators and Attenuation of Adaptive Immune Response by Vitamin D Vitamin D and Bone Health Cutting Edge: Vitamin D-Mediated Human Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on the Induction of Cathelicidin The Book of Why Fundamentals of Vitamin D Hormone-Regulated Gene Expression Enzymes Involved in the Activation and Inactivation of Vitamin D Vitamin D Status as an International Issue: National Surveys and the Frontiers in Pharmacology | www Current and Future Developments in the Treatment of Virus-Induced Hypercytokinemia Vitamin D Inhibits Monocyte/macrophage Proinflammatory Cytokine Production by Targeting MAPK Phosphatase-1 The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.Publisher's Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.